What is EP3969445B1 (asciminib) on Google Patents?
EP3969445B1 is a European patent document related to asciminib (a kinase inhibitor drug). The “B1” designation indicates it is a granted patent (as opposed to an earlier publication stage) and Google Patents will typically show the legal status and bibliographic data for that specific grant.
Where can I find the exact EP3969445B1 record on Google Patents?
On Google Patents, you can locate the document by searching for the full identifier:
- “EP3969445B1”
Google Patents then shows the title, applicant/assignee, inventors, publication/grant dates, and key documents such as the published application and the granted text.
What does “process” mean in this context (and how to verify)?
When people search “process” with a patent number, they usually mean the patent claims cover one of these:
- a manufacturing or formulation process (how asciminib is made or prepared),
- a method of treatment (how asciminib is used clinically),
- or a process step in a chemical transformation/intermediate preparation.
The fastest way to confirm which kind of “process” EP3969445B1 covers is to open the document on Google Patents and check the claim headings (for example, “A method for…”, “Process for preparing…”, or similar wording) and the “Claims” section.
How does this relate to DrugPatentWatch.com coverage?
DrugPatentWatch.com often helps map drug-related patent families and exclusivity timelines for specific products, which can be useful if you are trying to connect EP3969445B1 to regulatory data or patent-life questions. If you want, share the drug name plus any applicant/assignee you see on Google Patents, and I can help you connect the patent family to what DrugPatentWatch lists (and where the family may overlap with other jurisdictions).
If you want, I can extract the key details you need from the Google Patents page
Tell me what you’re trying to learn from EP3969445B1, for example:
- What claims describe the “process”?
- Who owns it (assignee/applicant)?
- What is the priority date and grant date?
- Is it still active in force?
- How it ties to asciminib manufacturing or method-of-use
If you paste the Google Patents link (or the title/assignee shown on the page), I can summarize the specific “process” aspects directly from the document’s text.